Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 29:14:27536130251375341.
doi: 10.1177/27536130251375341. eCollection 2025 Jan-Dec.

Acupuncture Treatment for Individuals With Myasthenia Gravis - A Pilot Randomized Clinical Trial

Affiliations

Acupuncture Treatment for Individuals With Myasthenia Gravis - A Pilot Randomized Clinical Trial

Amanda A Herrmann et al. Glob Adv Integr Med Health. .

Abstract

Background: Myasthenia gravis (MG) is a rare autoimmune disease resulting in muscle weakness. Although pharmacologic treatments are typically effective at managing symptoms, prolonged use is associated with safety issues. Acupuncture treatment may have a significant positive effect in treating MG symptoms and may enhance the efficacy of medications.

Objective: The overall goal was to examine the feasibility and safety of a pilot randomized controlled trial of acupuncture treatment in individuals with MG.

Methods: Participants were randomized into 2 arms: (1) immediate start and (2) delayed start. Participants in the immediate start arm underwent twice weekly acupuncture for 12 weeks, whereas participants in the delayed start arm underwent a 12-week delay period, followed by twice weekly acupuncture for 12 weeks. A base treatment of 21 acupoints was used for all study participants. Acupuncturists made a Traditional Chinese Medicine differential diagnosis to determine whether the patient was yang deficient, yin deficient, or stagnation pronounced, and could add up to 9 additional acupoints. Participants received the same acupuncture protocol for all 24 treatments.

Results: Twenty-four individuals with MG were enrolled in the study. The average age of participants was 62 (SD = 13) with an average of 8 years (SD = 9) between diagnosis and enrollment. Seventeen of the 24 individuals who signed the consent form completed 100% of acupuncture treatment sessions and completed the full study. Only 17 adverse events were determined to be definitely or probably related to treatment, which were mostly mild site reactions. Barriers to participation included transportation issues, travel time, and the overall time commitment.

Conclusion: The results demonstrated that acupuncture treatment was overall feasible and safe in individuals with MG. Participants also self-reported improvements in MG symptoms. Next steps will include development of an efficacy RCT with a rigorous study design to examine the clinical significance and efficacy of acupuncture for MG.

Keywords: activities of daily living; acupuncture; myasthenia gravis; neuromuscular disease; neurorehabilitation; quality of life; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Study Timeline of Participant Activities
Figure 2.
Figure 2.
Acupuncture Treatment Points Used for the Study Intervention. *Note: Bilateral Acupuncture Points Were Utilized, when Appropriate
Figure 3.
Figure 3.
Symptom Severity Scale Developed by Study Investigators for Determining Individualized Acupuncture Treatment Plan for the Study
Figure 4.
Figure 4.
CONSORT Diagram of Study Enrollment
Figure 5.
Figure 5.
Participant Assessment Data Availability. Note: Data labels represent the number of responses at each timepoint; Assessments from early withdrawals grouped with post-treatment 1 (Immediate start, n = 1) and post-treatment (Delayed start, n = 1)

References

    1. Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375(26):2570-2581. doi: 10.1056/NEJMra1602678 - DOI - PubMed
    1. Saccà F, Salort-Campana E, Jacob S, Cortés-Vicente E, Schneider-Gold C. Refocusing generalized myasthenia gravis: patient burden, disease profiles, and the role of evolving therapy. Eur J Neurol. 2024;31(6):e16180. doi: 10.1111/ene.16180 - DOI - PMC - PubMed
    1. Andersen LK, Jakobsson AS, Revsbech KL, Vissing J. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis. J Neurol. 2022;269(6):3086-3093. doi: 10.1007/s00415-021-10902-1 - DOI - PubMed
    1. Petersson M, Feresiadou A, Jons D, et al. Patient-reported symptom severity in a nationwide myasthenia gravis cohort: cross-sectional analysis of the Swedish GEMG study. Neurology. 2021;97(14):e1382-e1391. doi: 10.1212/wnl.0000000000012604 - DOI - PMC - PubMed
    1. Zhang X, Ding W, Wang Z, Gu X, Zhu W. The effectiveness and safety of acupuncture for the treatment of myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials. Ann Palliat Med. 2019;8(5):576-585. doi: 10.21037/apm.2019.10.10 - DOI - PubMed

LinkOut - more resources